BioCentury
ARTICLE | Company News

Roche acquires Cardion's CRB-15

July 22, 2003 7:00 AM UTC

Roche (SWX:ROCZ) will acquire Cardion's human interleukin IL-15 cytokine receptor blocker (CRB-15). The compound is in preclinical testing to treat rheumatoid arthritis and transplant rejection. ROCZ ...